Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Short report

Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications

Online download statistics by month:

Online download statistics by month: November 2018 to December 2020

	Abstract	Full	Pdf
Nov 2018	292	9	10
Dec 2018	313	1	2
Jan 2019	79	1	0
Feb 2019	127	0	3
Mar 2019	43	4	1
Apr 2019	34	0	0
May 2019	48	0	0
Jun 2019	467	0	0
Jul 2019	294	2	0
Aug 2019	45	0	0
Sep 2019	47	1	0
Oct 2019	72	1	0
Nov 2019	163	2	1
Dec 2019	101	1	1
Jan 2020	80	0	0
Feb 2020	118	0	0
Mar 2020	64	0	1
Apr 2020	78	1	1
May 2020	60	0	2
Jun 2020	35	0	0
Jul 2020	40	1	2
Aug 2020	248	8	4
Sep 2020	325	8	8
Oct 2020	92	4	4
Nov 2020	98	3	3
Dec 2020	106	0	0
Total	3469	47	43